Midventricular obstruction and clinical decision-making in obstructive hypertrophic cardiomyopathy

Herz

Volumn 31, Issue 9, 2006, Pages 871-876

  Cecchi, Franco ^a   Olivotto, Iacopo ^a   Nistri, Stefano ^a   Antoniucci, Davide ^a   Yacoub, Magdi H ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Alcohol ablation; Clinical management; Heart failure; Hypertrophic cardiomyopathy; Outflow obstruction; Surgical myectomy

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; VERAPAMIL;

ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CASE REPORT; CLINICAL DECISION MAKING; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEART OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LIFE EXPECTANCY; MISSENSE MUTATION; MITRAL VALVE; MUSCLE RESECTION; PATIENT REFERRAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; CARDIOLOGY; CARDIOMYOPATHY, HYPERTROPHIC; CRITICAL PATHWAYS; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; GERMANY; HUMANS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 33845865682     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2928-1     Document Type: Article

References (26)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
2. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
3. Autore C, Bernabò P, Barillà CS, et al. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 2005;45:1076-80.
4. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003;42:1687-713.
5. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is a disease characterized predominantly by left ventricular outflow tract obstruction. Circulation: in press (E pub 2006 Nov 06).
6. Sherrid MV, Barac I, McKenna WJ, et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;45:1251-8.
7. Yacoub MH. Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings. Circulation 2005;112:450-2.
8. Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001;104:2517-24.
9. Klues H, Roberts WC, Maron BJ. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 1991;84:1188-97.
10. Elliott PM, Gimeno JP, Tomé MT, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 2006;27:1933-41.
11. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
12. Maron BJ, Olivotto I, Maron MS. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators? Eur Heart J 2006;27:1895-7.
13. Maron BJ, Dearani JA, Ommen SR, et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2044-53.
14. Schoendube FA, Klues HG, Reith S, et al. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995;92:Suppl II:122-7.
15. Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;46:470-6.
16. Woo A, Williams WG, Choi R, et al. Clinical and echocardiographic determinants of long-term survival following surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005;111:2033-41.
17. Schulte HD, Borisov K, Gams E, et al. Management of symptomatic hypertrophic obstructive cardiomyopathy - long-term results after surgical therapy.Thorac Cardiovasc Surg 1999;47:213-8.
18. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-4.
19. Gietzen FH, Leuner CJ, Obergassel L, et al. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy: NYHA functional class III or IV and outflow obstruction only under provocable conditions. Circulation 2002;106:454-9.
20. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic cardiomyopathy. J Am Coll Cardiol 2001;38:1701-6.
21. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-8.
22. Ralph-Edwards A, Woo A, McCrindle BW, et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 2005;129:351-8.
23. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
24. Van der Lee C, ten Cate FJ, Geleijnse ML. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation 2005;112:482-8.
25. Firoozi S, Elliott PM, Sharma S, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy: a comparison of clinical, hemodynamic and exercise outcomes. Eur Heart J 2002;20:1617-24.
26. Minakata K, Dearani JA, Schaff HV, et al. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 2005;80:851-6.